Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Debt / NOTE 2.875% 2/1
-
Market price (% of par)
-
124.92%
-
Total 13F principal
-
$230,363,607
-
Principal change
-
+$219,886,607
-
Total reported market value
-
$305,680,689
-
Number of holders
-
19
-
Value change
-
+$292,645,387
-
Number of buys
-
17
Institutional Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 as of Q1 2024
As of 31 Mar 2024,
COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 was held by
19 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$230,363,607
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, STEELHEAD PARTNERS LLC, WOLVERINE ASSET MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, WHITEBOX ADVISORS LLC, BNP PARIBAS FINANCIAL MARKETS, BlueCrest Capital Management Ltd, AMERIPRISE FINANCIAL INC, and Jefferies Financial Group Inc..
This page lists
19
institutional bondholders reporting positions
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.